Latest news
UBS Keeps Their Buy Rating on Zai Lab Ltd (1ZLB) - The Globe and MailThe Globe and Mail · Sun, 09 Aug 2026 00:36:00 GMTCiti Sticks to Their Buy Rating for Zai Lab Ltd (1ZLB) - The Globe and MailThe Globe and Mail · Sun, 09 Aug 2026 00:36:00 GMTZai Lab Stock Slips Despite New FDA Orphan Win - TipRanksTipRanks · Fri, 07 Aug 2026 15:12:11 GMTZai Lab Files Latest Quarterly Report with U.S. Regulator - TipRanksTipRanks · Thu, 06 Aug 2026 23:53:41 GMTZai Lab’s Q2 Revenue Climbs as Oncology and Immunology Pipeline Nears Key Milestones - TipRanksTipRanks · Thu, 06 Aug 2026 22:55:21 GMTZai Lab reports Q2 EPS (46c), consensus (68c) - TipRanksTipRanks · Thu, 06 Aug 2026 18:11:28 GMTZai Lab says FDA grants Orphan Drug Designation for zocilurtatug pelitecan - TipRanksTipRanks · Mon, 03 Aug 2026 12:21:26 GMTZai Lab (1ZL) Q3 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 01 Aug 2026 09:42:27 GMT